
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

May 5, 2022
While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there...
Read article

April 29, 2022
An Interview with Gabriel Tremblay on his Poster Contributions to ISPOR US 2022
At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium...
Read article

April 13, 2022
Join Cytel’s HEOR Consultants at ISPOR US 2022
The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated...
Read article

November 11, 2021
Championing RWE & HEOR at Virtual ISPOR Europe 2021
The value of Real World Evidence (RWE) is well known to many stakeholders, but its full potential for market access and...
Read article

November 4, 2021
Join Cytel for HEOR Insights at ISPOR Europe 2021
The prominent European conference for Health Economics and Outcomes Research (HEOR), ISPOR Europe 2021, is around the...
Read article

April 29, 2021
Advances in HEOR: An Interview with Anna Forsythe
After twenty years in pharma, Anna Forsythe was frustrated by traditional vendors who used outdated methods to prepare...
Read article

November 5, 2020
Role of RWA in Transforming Oncological Research
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for...
Read article

October 22, 2020
An Interview with Bart Heeg (Part 2): New Trends in HEOR
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel...
Read article

October 20, 2020
Interview with Thomas Wilke: Health Economics/World Evidence Studies
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his...
Read article

October 14, 2020
The Increasing Importance of Health Economics
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic...
Read article

October 13, 2020
Introducing Observational Studies – Three Trends for Statisticians
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for...
Read article

September 22, 2020
LIBERTY claim analysis manuscript by Thomas Wilke and Sabrina Mueller
Research Scientists, Thomas Wilke and Sabrina Mueller recently published a manuscript on “Diabetes-Related...
Read article

July 22, 2019
Adaptive Design and Health Economic Analysis: Interview with Laura Flight
Health economics and adaptive design methods share common ground in that they both aim to support more efficient and...
Read article

April 13, 2016
HTAs: Adjusting Overall Survival for Treatment Switch
We continue our series of blogs covering the expert presentations from the EAST User Group Meeting. Consultant Claire...
Read article